$3.02
-0.10-3.21%
At close: -
$3.02
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Fulcrum Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:FULC | Benzinga
Fulcrum Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-0.260
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$80.00M
Analyze the earnings history of Fulcrum Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics | -$0.43 | -$0.26 | — | — | $0.00 | — | — | — | 05/12/2025 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.40 | -$0.29 | -$0.31 | -6.90% | $871.00K | — | $0.00 | — | 02/25/2025 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.39 | -$0.41 | -$0.32 | 21.95% | $759.00K | — | $0.00 | — | 11/13/2024 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.38 | -$0.01 | $0.87 | 8800.00% | $880.00K | $36.54M | $80.00M | 118.94% | 07/31/2024 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.41 | -$0.44 | -$0.43 | 2.27% | $259.00K | $360.00K | $0.00 | -100.00% | 05/13/2024 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.50 | -$0.43 | -$0.40 | 6.98% | $685.00K | $460.00K | $871.00K | 89.35% | 02/27/2024 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.51 | -$0.44 | -$0.39 | 11.36% | $1.18M | $1.05M | $759.00K | -27.71% | 11/07/2023 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.83 | -$0.44 | -$0.38 | 13.64% | $1.88M | $1.60M | $880.00K | -45.00% | 08/03/2023 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.64 | -$0.46 | -$0.41 | 10.87% | $2.59M | $1.13M | $259.00K | -77.08% | 05/15/2023 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.58 | -$0.49 | -$0.50 | -2.04% | $5.06M | $1.65M | $685.00K | -58.48% | 03/09/2023 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.57 | -$0.62 | -$0.51 | 17.74% | $4.93M | $2.54M | $1.18M | -53.43% | 11/08/2022 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.60 | -$0.66 | -$0.83 | -25.76% | $4.38M | $2.96M | $1.88M | -36.42% | 08/11/2022 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.54 | -$0.63 | -$0.64 | -1.59% | $4.79M | $3.94M | $2.59M | -34.21% | 05/09/2022 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.64 | -$0.73 | -$0.58 | 20.55% | $4.22M | $2.68M | $5.06M | 88.73% | 03/03/2022 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.70 | -$0.65 | -$0.57 | 12.31% | $1.85M | $2.25M | $4.93M | 119.33% | 11/04/2021 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.66 | -$0.62 | -$0.60 | 3.23% | $2.00M | — | $4.38M | — | 08/10/2021 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.81 | -$0.66 | -$0.54 | 18.18% | $750.00K | $1.42M | $4.79M | 237.25% | 05/06/2021 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.71 | — | -$0.64 | — | $0.00 | $1.31M | $4.22M | 222.52% | 03/04/2021 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.97 | -$0.65 | -$0.70 | -7.69% | $0.00 | $550.00K | $1.85M | 236.00% | 11/10/2020 | Get Alert |
| FULC | Fulcrum Therapeutics | -$9.21 | -$0.78 | -$0.66 | 15.38% | $0.00 | — | $2.00M | — | 08/11/2020 | Get Alert |
| FULC | Fulcrum Therapeutics | — | -$0.75 | -$0.81 | -8.00% | — | — | $750.00K | — | 05/13/2020 | Get Alert |
Fulcrum Therapeutics (FULC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-25 | $-0.31 | $-0.29 | -6.90 % |
| Q3 | 2024-11-13 | $-0.32 | $-0.41 | 21.9 % |
| Q2 | 2024-07-31 | $0.87 | $-0.01 | 8800.0 % |
| Q1 | 2024-05-13 | $-0.43 | $-0.44 | 2.27 % |
Fulcrum Therapeutics (FULC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2024-07-31 | $80.00M | $36.54M | 118.9 % |
| Q1 | 2024-05-13 | $0 | $360.00K | -100.0 % |
| Q4 | 2024-02-27 | $871.00K | $460.00K | 89.3 % |
| Q3 | 2023-11-07 | $759.00K | $1.05M | -27.7 % |
FAQ
When is Fulcrum Therapeutics (NASDAQ:FULC) reporting earnings?
Fulcrum Therapeutics (FULC) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on February 25, 2025 for Q4.
What were the latest earnings per share (EPS) for Fulcrum Therapeutics (NASDAQ:FULC)?
The Actual EPS was $-0.31, which missed the estimate of $-0.29.
What were Fulcrum Therapeutics’s (NASDAQ:FULC) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.